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Abstract
This was an observational study offering a screening program for
diabetes in a health clinic in Puerto Ayora town on Santa Cruz Is-
land to determine the prevalence of this disorder and identify those
at risk. A 1-month screening program was undertaken. Of 141 pa-
tients screened, 85% of men and 83% of women were overweight
or obese; 16 (11%) had suspected undiagnosed diabetes and 22
(16%) were at high risk of developing diabetes. This is the first re-
ported study of glucose intolerance prevalence in Galapagos. Ur-
gent education and prevention programs are required to address
this public health problem.
Objective
Diabetes mellitus is an increasing health problem, imposing a pub-
lic health burden on health systems worldwide (1). The Interna-
tional Diabetes Federation (IDF) reports a prevalence of 6% (1 in
18 adults)  in  Ecuador  and US $562.50 annual  health  care  ex-
penditure per person (2).
The onset of type 2 diabetes can be delayed or prevented; effect-
ive management reduces risk of complications. Self-management
is the cornerstone of effective care (3). Our study was observation-
al and offered a screening and education program for diabetes in a
health clinic in the town of Puerto Ayora to determine prevalence
of this disorder and identify those at risk.
Methods
The Galapagos archipelago, with a population of approximately
23,000 (48.2% female), is 1,000 km (621 miles) off Ecuador’s
coast. It consists of 20 islands (5 of which are inhabited) and 250
islets (4). Santa Cruz is the main island and has 61% of the popu-
lation (approximately 14,000); 78% of the population live in the
main town, Puerto Ayora. The age structure of the population on
the island consists of 28% aged less than 15 years, 68% aged 15 to
64 years, and 4% aged 65 years or older(5).
Between October 31 and November 29, 2012, a diabetes screen-
ing program was offered in the Centro de Salud clinic in Puerto
Ayora. The diabetes screening program was advertised weekly on
the local television news channel, radio station, and on the Inter-
net.  For  1  day  (November  14,  2012,  National  Diabetes  Day)
screening was offered at a stall set up in the local park by the port.
The International Expert Committee guidelines for diagnosis were
used: fasting glucose 126 mg/dL or higher (≥7 mmol/L) for dia-
gnosing diabetes and fasting glucose 100 to 125 mg/dL (5.6–6.9
mmol/L) for diagnosing high-risk individuals with impaired fast-
ing glucose (IFG) (1,6). The committee’s guidelines define high-
risk individuals as adults whose body mass index (BMI) is 25 kg/
m2 or higher with 1 or more of the following risk factors: physical
inactivity, first-degree relative with diabetes, high risk race/ethni-
city (African American, Latino, Native American, Asian Americ-
an, Pacific Islander), hypertension 140/90 mm Hg or higher or un-
dergoing therapy for hypertension, and history of cardiovascular
disease. We used capillary blood glucose testing on a single fin-
ger prick test (7–9).
At presentation to the health clinic, data on the following personal
demographics and physical measurements were collected: age,
smoking status, personal history of diabetes, weight, height, fast-
ing capillary glucose, and blood pressure. Glucose was tested with
Contour test stripes using a Contour (Bayer) glucometer. Weight
was measured on a Weigh Beam Eye-Level (Detecto Scale Com-
pany) scale (0–175 kg or 0–400 lb).
All patients were provided with education on nutrition and life-
style changes. Patients with abnormal results were given advice
about health concerns and information about improving their diet
and increasing physical activity. Appointments were made for re-
peat testing within 1 to 2 weeks.
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Results
From 5  to  15  patients,  including  pediatric  patients,  presented
themselves each day to the clinic for various health reasons and
were invited to participate in the screening program. Patients were
excluded if under the age of 18 years, pregnant, or had not fasted.
In total, 141 patients were screened for fasting glucose, and 135
had  their  weight  measured.  Six  patients  refused  to  have  their
weight measured or were unable to be weighed (eg, in a wheel-
chair).
Among those screened, 59.6% were women, and ages ranged from
20 to 78 years (mean, 46 y) (Table 1). Eighty women and 55 men
agreed to have their weight measured, and weights ranged from 45
to 120 kg (BMI, 20–44 kg/m2) for women and 58 to 120 kg (BMI
23–39 kg/m2) for men; 41.8% of men and 45.0% of women were
overweight (BMI 25–29.9 kg/m2), and 43.6% men and 37.5% of
women were obese (BMI ≥30 kg/m2). Fasting capillary glucose
varied widely, ranging from 51 to 346 mg/dL.
Of the 141 patients screened, 23 (16.3%) reported that they had
previously been told they have diabetes. Of these, 9 were taking at
least  1  medication:  6  were taking metformin;  1,  sitagliptin;  1,
glimepiride; and 2, glibenclamide. No patients were having regu-
lar follow-up on the mainland.
Among patients who were not known to have diabetes, 16 had
raised fasting glucose levels; 22 patients had IFG (Table 2). There-
fore, within this screened population, 11.3% had a likely new dia-
gnosis of diabetes and 15.6% were at high risk of developing dia-
betes in the future.
Discussion
Our findings suggest substantial numbers of people have undia-
gnosed, or are at high risk of developing, diabetes. These figures
appear higher than those reported by IDF and World Health Or-
ganization for Ecuador, especially for the prevalence of obesity
(2,10) (Appendix A). Obesity is strongly linked with diabetes risk
(11). No published data was found on rates of exercise or hyper-
tension in Galapagos.
Ecuador has close ties to the United States and may be sensitive to
US economic, industrial, and cultural influences (12). Galapagos
is  heavily  reliant  on  tourism,  and  with  an  annual  population
growth of 6.4%, may be at higher risk of increasing obesity (4).
Landscape on the islands is not amenable to farming, and farming
is carefully managed to protect  endemic species.  Similar  situ-
ations have been noted in other island populations, such as the Pa-
cific islands, with increasing prevalence of diabetes and obesity
due to rapid population and economic growth and transition to
westernization (13). Appendix B shows a comparison of data for
diabetes and obesity for Ecuador and other island populations.
Limitations of this study are that it has a small sample size and
high dropout rate for repeat checks. Caution should be used when
extrapolating outside this population. Bias in sampling may have
occurred because only those individuals motivated to seek health
advice were screened. Our study may overestimate the prevalence
of obesity, as it is unlikely to have data on the more physically act-
ive, such as fishermen or cruise ship employees.
Individuals with impaired fasting glucose or impaired glucose tol-
erance are at high risk for developing diabetes. For populations
like that of the Galapagos Islands, which already has multiple risk
factors for poor health, there is an urgent need for action. Presid-
ent Rafael Correa suggested introducing a new tax on junk food
suppliers to try to address Ecuador’s rapidly rising obesity rates
(14).
Acknowledgments
No financial support was received for this work.
Author Information
Corresponding Author: Nicola Tufton, MBBS, BSc, Department
of Diabetes and Metabolism, Diabetes Centre, Homerton Hospital,
Homerton Row, London, United Kingdom, E9 6SR. Telephone:
020 8510 7647. Email: nicola.tufton1@nhs.net.
Author Affiliation: Tahseen Chowdhury, Royal London Hospital,
BartsHealth NHS Trust, London, United Kingdom.
References
American Diabetes Association. Standards of medical care in
diabetes — 2013. Diabetes Care 2013;36(Suppl 1):S11–66.
  1.
International  Diabetes  Federation.  IDF  diabetes  atlas,  6th
edition.  Brussels  (BE):  International  Diabetes  Federation,
2013. http://www.idf.org/diabetesatlas. Accessed March 22,
2015.
  2.
Department  of  Health.  National  Service  Framework  for
diabetes:  standards.  2001.  http://www.gov.uk/government/
uploads/system/uploads/attachment_data/file/198836/
National_Service_Framework_for_Diabetes.pdf.  Accessed
August 2013.
  3.
León MG, Salazar GC. Population and migration in Galapagos.
In:  Galapagos report  2011–2012.  Puerto Ayora,  Galapagos
(EC): GNPS, GCREG, CDF, and GC; 2013. p. 44–51.
  4.
PREVENTING CHRONIC DISEASE VOLUME 12, E94
PUBLIC HEALTH RESEARCH, PRACTICE, AND POLICY           JUNE 2015
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services,
the Public Health Service, the Centers for Disease Control and Prevention, or the authors’ affiliated institutions.
2       Centers for Disease Control and Prevention  •  www.cdc.gov/pcd/issues/2015/15_0108.htm
Fascículo Provincial Galápagos. Resultados del censo 2010de
población  y  vivienda  en  el  Ecuador.  Instituto  Nacional  de
Estadística y Censos. http://www.ecuadorencifras.gob.ec/wp-
content/descargas/Manu-lateral/Resultados-provinciales/
galapagos.pdf. Accessed May 16, 2015.
  5.
International  Expert  Committee.  International  Expert
Committee report on the role of the A1C assay in the diagnosis
of diabetes. Diabetes Care 2009;32(7):1327–34.
  6.
Zhou X, Pang Z,  Gao W, Wang S,  Zhang L,  Ning F,  et  al.
Performance of an A1C and fasting capillary blood glucose test
for  screening  newly  diagnosed  diabetes  and  pre-diabetes
defined by an oral glucose tolerance test in Qingdao, China.
Diabetes Care 2010;33(3):545–50.
  7.
Toscano CM, Duncan BB, Mengue SS, Polanczyk CA, Nucci
LB,  Costa  e  Forti  A,  et  al.  Initial  impact  and  cost  of  a
nationwide  population  screening  campaign  for  diabetes  in
Brazil:  a  follow  up  study.  BMC  Health  Serv  Res  2008;
8(1):189.
  8.
Spijkerman  AM,  Adriaanse  MC,  Dekker  JM,  Nijpels  G,
Stehouwer CD, Bouter LM, et al. Diabetic patients detected by
population-based stepwise screening already have a diabetic
cardiovascular risk profile. Diabetes Care 2002;25(10):1784–9.
  9.
World Health Organization. Global Health Observatory (GHO)
data. http://www.who.int/gho/ncd/risk_factors/en/. Accessed
March 22, 2015.
10.
Amos AF, McCarty DJ, Zimmet P. The rising global burden of
diabetes and its complications: estimates and projections to the
year 2010. Diabet Med 1997;14(Suppl 5):S1–85.
11.
Bernstein A. Emerging patterns in overweight and obesity in
Ecuador. Rev Panam Salud Publica 2008;24(1):71–4.
12.
Hosey  G,  Aitaoto  N,  Satterfield  D,  Kelly  J,  Apaisam  CJ,
Belyeu-Camacho T, et al. The culture, community, and science
of type 2 diabetes prevention in the US Associated Pacific
Islands. Prev Chronic Dis 2009;6(3):A104. Erratum in: Prev
Chronic Dis 2011;8(1):A28. http://www.cdc.gov/pcd/issues/
2009/jul/08_0129.htm. Accessed March 22, 2015.
13.
Tegel  S.  Ecuador  to  tax  fast  food  in  effort  to  halt  soaring
obesity rate. The Independent. 2014Sept 11.
14.
PREVENTING CHRONIC DISEASE VOLUME 12, E94
PUBLIC HEALTH RESEARCH, PRACTICE, AND POLICY           JUNE 2015
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services,
the Public Health Service, the Centers for Disease Control and Prevention, or the authors’ affiliated institutions.
www.cdc.gov/pcd/issues/2015/15_0108.htm • Centers for Disease Control and Prevention       3
Tables
Table 1. Demographics of Patients and Fasting Glucose Readings, Puerto Ayora, Galapagos, Ecuador, 2012
Statistic Age, y
Fasting
Glucose, mg/dL
(n = 141)
Fasting
Glucose,
mmol/L (n =
141)
Weighta Body Mass Indexa
Women, kg (n =
80)
Men, kg (n =
55)
Women, kg/m2 (n
= 80)
Men, kg/m2 (n
= 141)
Mean 46 110 6.1 71 80 29 29
Range 20–78 51–346 2.83–19.2 45–120 58–120 20–44 23–39
Median 44 96 5.3 65 80 29 28
Mode 40 81 4.5 67 80.5 29 29
a 135 patients had weight measured; 6 patients either refused to be weighed or could not be weighed (eg, in wheelchair, wearing plaster cast).
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Table 2. Fasting Capillary Glucose Readings (N = 141), Puerto Ayora, Galapagos, Ecuador, 2012
Capillary Glucose
Readings N (%)
No. (%) With Known
Diabetes Mellitus
No. (%) With
Suspected New
Diagnosis of
Diabetes Mellitusa
No. (%) Men With
Suspected New
Diagnosis of Diabetes
Mellitusa
No. (%) Women With
Suspected New
Diagnosis of Diabetes
Mellitusa
≥7.0 mmol/L 30 (21.3) 14 (9.9) 16 (11.3) 5 (31) 11 (69)
5.6–6.9 mmol/L 26 (18.4) 4 (2.8) 22 (15.6) 10 (45) 12 (55)
a Based on only 1 fasting reading.
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Appendix A. Prevalence Data for Obesity and Diabetes for Ecuador
Characteristic
World Health Organization (10)
International Diabetes
Federation (2)Men Women
Diabetes 8.7% 9.4% 5.9%
Overweight (body mass index >25 kg/m2) 51.8% 60.2%
NA
Obese (body mass index >30 kg/m2) 15.7% 28.2%
Abbreviation: NA, not available.
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Appendix B. Prevalence of Diabetes and Obesity Across Various Island
Populations
Location Population
Prevalence of Diabetes,
%
Prevalence of Overweight and Obesity (BMI >25
kg/m2), %
Men Women
Puerto Ayora (this study) 14,000 11.3 85 82.5
Santa Cruz 14,000 11a NA NA
Republic of Palau 13,000 18–38.9b,c 81.9d 81.7d
Republic Marshall Islands 32,000 26.5–29.8c,d 78.2d 82d
Federated States of
Micronesia
54,000 24.4−36.6c,d 71.4d 82.5d
American Samoa 97,000 47.3b 82.6d 88.9d
Guam 107,000 11–20.1b,c NA NA
British Virgin Islands 18,000 12.6c NA NA
Anguilla 9,000 12.6c NA NA
Abbreviation: BMI, body mass index; NA, information is not available.
a Wilson R. Ponte en forma: an assessment of the health needs of the population of Santa Cruz, Galapagos. August 2009 (unpublished data).
b Hosey et al (13).
c International Diabetes Federation (2).
d World Health Organization (10).
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